CARs in the Lead Against Multiple Myeloma

Overview of attention for article published in Current Hematologic Malignancy Reports, February 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#33 of 449)
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 11 X users

patent: 9 patents

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 87 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 9 patents that reference this research output.

Method of assessing activity of recombinant antigen receptors

Grant US-11851679-B2

United States of America

A METHOD OF ENGINEERING NATURAL KILLER-CELLS TO TARGET BCMA-POSITIVE TUMORS

Application EP-4031577-A4

European Patent Office

Antibodies targeting B-cell maturation antigen and methods of use

Grant US-11725059-B2

United States of America

Antibodies and chimeric antigen receptors specific for B-cell maturation antigen

Grant US-11623961-B2

United States of America

BCMA (CD269) specific chimeric antigen receptors for cancer immunotherapy

Grant US-11498971-B2

United States of America

TWO CHIMERIC ANTIGEN RECEPTORS SPECIFICALLY BINDING CD19 AND IGKAPPA

Application WO-2020011706-A1

World Intellectual Property Organisation (WIPO)

BCMA (CD269) specific chimeric antigen receptors for cancer immunotherapy

Application US-10316101-B2

United States of America

BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR, CD19-TARGETING CHIMERIC ANTIGEN RECEPTOR, AND…

Application WO-2019099639-A1

World Intellectual Property Organisation (WIPO)

BCMA (CD269) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY

Application US-20170183418-A1

United States of America